Digital letters aim to speed up Life-Saving heart failure care
NCT ID NCT05890131
Summary
This study is testing a new digital strategy to help more people with heart failure start taking a beneficial medication called an SGLT-2 inhibitor. Researchers are sending official digital letters to eligible patients in Denmark, inviting them to be evaluated for the medication. The goal is to see if this approach gets more people on the treatment and starts it faster than the usual process, which could lead to better health outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amager-Hvidovre-Glostrup Hospital
Hvidovre, 2650, Denmark
-
Bispebjerg-Frederiksberg Hospital
Copenhagen, 2400, Denmark
-
Herlev and Gentofte University Hospital
Hellerup, 2900, Denmark
-
Nordsjællands Hospital
Hillerød, 3400, Denmark
-
Sjællands Universitetshospital - Roskilde
Roskilde, 4000, Denmark
Conditions
Explore the condition pages connected to this study.